`37629
`
`EXHIBIT A
`
`Biocon Exhibit 1069 Page 1
`
`
`
`Case 1:22-cv-00061-TSK-JPM Document 484-2 Filed 05/19/23 Page 2 of 2 PageID #:
`37630
`
`Gregory, Teagan
`M710 Team; Gordon Copland; "Jamie O"Brien"
`Eylea; REGENERON PATENT; Steve Ruby; "David Pogue"
`Regeneron v. Mylan (No. 22-cv-61)
`Wednesday, May 17, 2023 11:58:16 AM
`
`From:
`To:
`Cc:
`Subject:
`Date:
`
`Counsel:
`
`Regeneron represented to the Court that it will proceed to trial in June on no more than 12 patent
`claims. Consistent with its representation and the parties’ recent correspondence on this issue,
`Regeneron hereby elects to proceed to trial in June on the following patent claims:
`
`U.S. Patent No. 10,888,601: Claims 11, 19
`U.S. Patent No. 11,084,865: Claims 4, 7, 9, 11, 14-17
`U.S. Patent No. 11,253,572: Claims 6, 25
`
`Following Regeneron’s election to proceed with these claims for trial in June, Mylan’s pending
`motion for summary judgment is moot with respect to all challenged claims other than claim 6 of
`U.S. Patent No 11,253,572. Please confirm that Mylan will so notify the Court of the status of its
`summary judgment motion.
`
`Best,
`Teagan
`
`Teagan James Gregory
`Williams & Connolly LLP
`680 Maine Avenue SW, Washington, DC 20024
`(P) 202-434-5178 | (F) 202-434-5029
`tgregory@wc.com | www.wc.com/tgregory
`
`Biocon Exhibit 1069 Page 2
`
`